C12Y 301/16
Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters
Official title: Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.16)
C12Y301/16 (Exonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters) appears on 5 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 11
- Assignees
- 7
- Inventors
- 25
- Latest grant
- 14 Jan 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Direct cloning14 Jan 2025US 12,195,732 B2Gene Bridges GMBH
- Genome editing systems comprising repair-modulating enzyme molecules and methods of their use7 Mar 2023US 11,597,924 B2Editas Medicine, Inc.
- Methods for generating structure-switching aptamers and uses thereof2 Nov 2021US 11,162,960 B2The Florida International University Board of Trustees
- Direct cloning15 Oct 2019US 10,443,051 B2Gene Bridges GMBH
- DNA repair enzymes, nucleic acids encoding DNA repair enzymes and methods of using them6 Sep 2005US 6,939,949 B2Riken
- Method, kits and system for dual labeling of nucleic acids30 Apr 2026US 2026/0117278 A1
- Methods of treating neurodegenerative conditions and compositions therefor26 Dec 2024US 2024/0424142 A1Yale University
- Genome editing systems comprising repair-modulating enzyme molecules and methods of their use25 Apr 2024US 2024/0132877 A1Editas Medicine, Inc.
- Nucleobase Editors16 Feb 2023US 2023/0051661 A1Agency for Science, Technology and Research
- Direct cloning10 Sep 2020US 2020/0283759 A1Gene Bridges GMBH
Most cited
By later US patents